Vcb Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 M
- Revenue Growth 11.78%
- Profit Growth -75.74%
- Ebitda 192.34%
- Net Worth -19.38%
- Total Assets 137.33%
About Vcb Life Sciences
Vcb Life Sciences Private Limited (VLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 November 2018 (Six years and three months 20 days old ). Its registered office is in Faridabad, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹8.00 M.
Shilpa Agrawal and Dharmendra Agarwal serve as directors at the Company.
Company Details
- Location
Faridabad, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100HR2018PTC076828
- Company No.
076828
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Vcb Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shilpa Agrawal  | Director | 20-Dec-2020 | Current |
| Dharmendra Agarwal | Director | 06-Nov-2018 | Current |
Financial Performance of Vcb Life Sciences.
Vcb Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.78% increase. The company also saw a substantial fall in profitability, with a 75.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vcb Life Sciences?
In 2023, Vcb Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jam Healthcare (India) Private LimitedShilpa Agrawal and Dharmendra Agarwal are mutual person
- Garg Surgical Point Private Limited
Shilpa Agrawal and Dharmendra Agarwal are mutual person
- Myfastad Medical Services Private Limited
Shilpa Agrawal is a mutual person
Charges (Loans)
₹8.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2021 | Hdfc Bank Limited | ₹8.00 M | Open |
How Many Employees Work at Vcb Life Sciences?
Unlock and access historical data on people associated with Vcb Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vcb Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vcb Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
